医学
肾功能
心脏病学
内科学
冠状动脉疾病
优势比
糖尿病
风险因素
流行病学
肾脏疾病
病理生理学
冠状动脉粥样硬化
疾病
回顾性队列研究
弗雷明翰风险评分
冠心病
可能性
风险评估
动脉
作者
Metin Karayakalı,Hasan Kadi,Kayıhan Karaman,Ataç Çelik,Kerem Özbek,İbrahim Halil Damar,Çağrı Zorlu,Hasan Atmaca,Özkan Vural,Orhan Önalan
出处
期刊:Angiology
[SAGE]
日期:2026-01-31
卷期号:: 33197261416667-33197261416667
标识
DOI:10.1177/00033197261416667
摘要
The American Heart Association’s Predicting Risk of cardiovascular disease EVENTs (PREVENT) equations established estimated glomerular filtration rate (eGFR) as a component of cardiovascular risk assessment. However, the anatomical substrate underlying this risk—coronary atherosclerotic burden—remains inadequately characterized across renal function spectrum. This retrospective study included 1181 patients (mean age: 60.2 ± 8.9 years, 65.7% male) undergoing elective coronary angiography. Patients divided groups using eGFR; eGFR ≥90 (n = 596), 60 to 89 (n = 497), and 30 to 59 mL/min/1.73 m 2 (n = 88) were evaluated by stratification. Coronary atherosclerotic burden was determined using Gensini score. eGFR demonstrated a strong correlation with Gensini score (ρ = −0.352, P < .001). Each 10 mL/min/1.73 m 2 eGFR decline conferred 40% increased odds of severe coronary atherosclerosis (odds ratio [OR] = 0.960, 95% CI: 0.951-0.970, P < .001). Patients with eGFR 30 to 59 mL/min/1.73 m 2 exhibited 6-fold higher odds compared with preserved renal function (OR 6.073, 95% CI: 3.352-11.005, P < .001), independent of traditional risk factors. This study provides an anatomical validation for incorporating eGFR into cardiovascular risk assessment. Our angiographic evidence demonstrates that even mild renal dysfunction is accompanied by increased atherosclerotic burden. These findings bridge the gap between epidemiological risk prediction and pathophysiological reality, reinforcing the cardiovascular-kidney-metabolic health continuum and supporting aggressive risk modification strategies in patients with declining renal function, particularly among diabetic women.
科研通智能强力驱动
Strongly Powered by AbleSci AI